{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T22:20:41Z","timestamp":1775082041270,"version":"3.50.1"},"reference-count":23,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clin Nucl Med"],"published-print":{"date-parts":[[2019,1]]},"abstract":"<jats:sec>\n            <jats:title>Objective<\/jats:title>\n            <jats:p>Normalization to an appropriate reference region in <jats:sup>18<\/jats:sup>F-FDG PET imaging may enhance diagnostic performance in Huntington disease (HD). We aimed to identify stable brain areas that could be used to model neurometabolic degeneration in HD correlating imaging (SUVr<jats:sub>values<\/jats:sub> at the basal ganglia [BBGG]) and clinical parameters (disease burden score [DBS]).<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Materials and Methods<\/jats:title>\n            <jats:p>We performed brain <jats:sup>18<\/jats:sup>F-FDG PET\/CT in 38 manifest HD patients (mean<jats:sub>age<\/jats:sub> \u00b1 SD, 54 \u00b1 14.3 years; CAG<jats:sub>repeats<\/jats:sub> \u00b1 SD, 44.2 \u00b1 3.1), 20 premanifest HD patients (mean<jats:sub>age<\/jats:sub> \u00b1 SD, 42.7 \u00b1 11.7 years; CAG<jats:sub>repeats<\/jats:sub> \u00b1 SD, 40 \u00b1 3.8), and 18 healthy controls (NC; mean<jats:sub>age<\/jats:sub> \u00b1 SD, 45 \u00b1 13.2 years). For quantitative analysis, we selected (<jats:italic toggle=\"yes\">a<\/jats:italic>) defined reference regions from the Montreal Neurological Institute space atlas (pons, whole cerebellum, cerebral white matter, thalamus, and a pons\u2013cerebellar vermis region of interest), and (<jats:italic toggle=\"yes\">b<\/jats:italic>) reference clusters obtained by voxelwise statistical comparison across groups (<jats:italic toggle=\"yes\">P<\/jats:italic> &lt; 0.05 FWE; extent voxel threshold k = 200). Each candidate reference region and reference cluster was quantitatively assessed using imaging and clinical parameters.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results<\/jats:title>\n            <jats:p>Comparing HD and NC groups, we obtained a reference cluster in the cerebellum, and in temporal and frontal lobes. Comparing manifest HD and premanifest HD patients, we observed reference clusters in the cerebellum, pons, thalamus, parietal lobe, and cuneus. The set of reference regions showed a significant correlation between SUVr<jats:sub>values<\/jats:sub> at the BBGG and DBS in all HD patients. In premanifest HD patients, the correlation between SUVr<jats:sub>values<\/jats:sub> at the BBGG and DBS was significant using the pons\u2013cerebellar vermis region of interest, the thalamus as defined reference regions, and the pons and thalamus as reference clusters. In manifest HD patients, the correlation was significant using the temporal and white matter frontal lobe clusters. Variance between SUVr<jats:sub>values<\/jats:sub> in the set of reference regions and reference clusters was minimal within NC.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusions<\/jats:title>\n            <jats:p>The pons may be a stable and reliable region to calculate SUVr<jats:sub>values<\/jats:sub> to model the neurometabolic degeneration in quantitative <jats:sup>18<\/jats:sup>F-FDG PET imaging in HD.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/rlu.0000000000002329","type":"journal-article","created":{"date-parts":[[2018,10,16]],"date-time":"2018-10-16T17:02:33Z","timestamp":1539709353000},"page":"e1-e5","source":"Crossref","is-referenced-by-count":14,"title":["Selection of Reference Regions to Model Neurodegeneration in Huntington Disease by 18F-FDG PET\/CT Using Imaging and Clinical Parameters"],"prefix":"10.1097","volume":"44","author":[{"given":"Diego Alfonso","family":"L\u00f3pez Mora","sequence":"first","affiliation":[{"name":"Nuclear Medicine Department, Hospital de la Santa Creu i Sant Pau, Autonomous University of Barcelona;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Frederic","family":"Sampedro","sequence":"additional","affiliation":[{"name":"Biomedical Research Institute (IIB-Sant Pau);"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Valle","family":"Camacho","sequence":"additional","affiliation":[{"name":"Nuclear Medicine Department, Hospital de la Santa Creu i Sant Pau, Autonomous University of Barcelona;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alejandro","family":"Fern\u00e1ndez","sequence":"additional","affiliation":[{"name":"Nuclear Medicine Department, Hospital de la Santa Creu i Sant Pau, Autonomous University of Barcelona;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francisco","family":"Fuentes","sequence":"additional","affiliation":[{"name":"Nuclear Medicine Department, Hospital de la Santa Creu i Sant Pau, Autonomous University of Barcelona;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joan","family":"Duch","sequence":"additional","affiliation":[{"name":"Nuclear Medicine Department, Hospital de la Santa Creu i Sant Pau, Autonomous University of Barcelona;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jes\u00fas","family":"P\u00e9rez-Perez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sa\u00fcl","family":"Mart\u00ednez-Horta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Juan","family":"Mar\u00edn-Lahoz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anna","family":"Dom\u00e8nech","sequence":"additional","affiliation":[{"name":"Nuclear Medicine Department, Hospital de la Santa Creu i Sant Pau, Autonomous University of Barcelona;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Albert","family":"Flotats","sequence":"additional","affiliation":[{"name":"Nuclear Medicine Department, Hospital de la Santa Creu i Sant Pau, Autonomous University of Barcelona;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Montserrat","family":"Estorch","sequence":"additional","affiliation":[{"name":"Nuclear Medicine Department, Hospital de la Santa Creu i Sant Pau, Autonomous University of Barcelona;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jaime","family":"Kulisevsky","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ignasi","family":"Carri\u00f3","sequence":"additional","affiliation":[{"name":"Nuclear Medicine Department, Hospital de la Santa Creu i Sant Pau, Autonomous University of Barcelona;"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"bib1-20230925","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1016\/0092-8674(93)90585-E","article-title":"A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington's disease chromosomes","volume":"72","year":"1993","journal-title":"Cell"},{"key":"bib2-20230925","doi-asserted-by":"crossref","first-page":"2183","DOI":"10.1007\/s00259-016-3445-y","article-title":"Striatal hypometabolism in premanifest and manifest Huntington's disease patients","volume":"43","year":"2016","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"bib3-20230925","doi-asserted-by":"crossref","first-page":"1988","DOI":"10.1002\/jcp.25666","article-title":"Molecular imaging of Huntington's disease","volume":"232","year":"2017","journal-title":"J Cell Physiol"},{"key":"bib4-20230925","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1016\/j.expneurol.2008.12.015","article-title":"Functional imaging in Huntington's disease","volume":"216","year":"2009","journal-title":"Exp Neurol"},{"key":"bib5-20230925","doi-asserted-by":"crossref","first-page":"1030","DOI":"10.1007\/s00259-012-2114-z","article-title":"18F-FDG PET uptake in the pre-Huntington disease caudate affects the time-to-onset independently of CAG expansion size","volume":"39","year":"2012","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"bib6-20230925","doi-asserted-by":"crossref","first-page":"21","DOI":"10.3988\/jcn.2013.9.1.21","article-title":"Decreased metabolism in the cerebral cortex in early-stage Huntington's disease: a possible biomarker of disease progression?","volume":"9","year":"2013","journal-title":"J Clin Neurol"},{"key":"bib7-20230925","first-page":"1591","article-title":"Metabolic network abnormalities in early Huntington's disease: an [18F]FDG PET study","volume":"42","year":"2001","journal-title":"J Nucl Med"},{"key":"bib8-20230925","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1007\/s00259-016-3324-6","article-title":"Current status of PET imaging in Huntington's disease","volume":"43","year":"2016","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"bib9-20230925","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.neuroimage.2008.07.015","article-title":"SPM-based count normalization provides excellent discrimination of mild Alzheimer's disease and amnestic mild cognitive impairment from healthy aging","volume":"44","year":"2009","journal-title":"Neuroimage"},{"key":"bib10-20230925","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1097\/RLU.0b013e3182478bf2","article-title":"Apparent relative hypermetabolism of selective brain areas in Huntington disease and importance of reference region for analysis","volume":"37","year":"2012","journal-title":"Clin Nucl Med"},{"key":"bib11-20230925","article-title":"UC Berkeley FDG meta-ROI methods","year":"2011","journal-title":"Alzheimer Dis Neuroimaging Initiat"},{"key":"bib12-20230925","doi-asserted-by":"crossref","first-page":"e55415","DOI":"10.1371\/journal.pone.0055415","article-title":"Reference cluster normalization improves detection of frontotemporal lobar degeneration by means of FDG-PET","volume":"8","year":"2013","journal-title":"PLoS One"},{"key":"bib13-20230925","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1002\/mds.870100213","article-title":"Functional decline in Huntington's disease","volume":"10","year":"1995","journal-title":"Mov Disord"},{"key":"bib14-20230925","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1016\/S1474-4422(09)70170-X","article-title":"Biological and clinical manifestations of Huntington's disease in the longitudinal TRACK-HD study: cross-sectional analysis of baseline data","volume":"8","year":"2009","journal-title":"Lancet Neurol"},{"key":"bib15-20230925","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1002\/ana.410410521","article-title":"CAG repeat number governs the development rate of pathology in Huntington's disease","volume":"41","year":"1997","journal-title":"Ann Neurol"},{"key":"bib16-20230925","doi-asserted-by":"crossref","first-page":"2103","DOI":"10.1007\/s00259-009-1264-0","article-title":"EANM procedure guidelines for PET brain imaging using [18F]FDG, version 2","volume":"36","year":"2009","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"bib17-20230925","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.pscychresns.2007.11.004","article-title":"Choice of reference area in studies of Alzheimer's disease using positron emission tomography with fluorodeoxyglucose-F18","volume":"164","year":"2008","journal-title":"Psychiatry Res"},{"key":"bib18-20230925","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1111\/bpa.12115","article-title":"Huntington's disease (HD): degeneration of select nuclei, widespread occurrence of neuronal nuclear and axonal inclusions in the brainstem","volume":"24","year":"2014","journal-title":"Brain Pathol"},{"key":"bib19-20230925","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1111\/bpa.12426","article-title":"Huntington's disease (HD): the neuropathology of a multisystem neurodegenerative disorder of the human brain","volume":"26","year":"2016","journal-title":"Brain Pathol"},{"key":"bib20-20230925","first-page":"215","article-title":"Brain white-matter volume loss and glucose hypometabolism precede the clinical symptoms of Huntington's disease","volume":"47","year":"2006","journal-title":"J Nucl Med"},{"key":"bib21-20230925","doi-asserted-by":"crossref","first-page":"1405","DOI":"10.1093\/brain\/113.5.1405","article-title":"Cortical and subcortical glucose consumption measured by PET in patients with Huntington's disease","volume":"113","year":"1990","journal-title":"Brain"},{"key":"bib22-20230925","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1038\/jcbfm.1985.24","article-title":"Glucose metabolic rate kinetic model parameter determination in humans: the lumped constants and rate constants for [18F] fluorodeoxyglucose and [11C] deoxyglucose","volume":"5","year":"1985","journal-title":"J Cereb Blood Flow Metab"},{"key":"bib23-20230925","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.neuroimage.2006.05.061","article-title":"Automatic anatomical brain MRI segmentation combining label propagation and decision fusion","volume":"33","year":"2006","journal-title":"Neuroimage"}],"container-title":["Clinical Nuclear Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/00003072-201901000-00029","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,25]],"date-time":"2023-09-25T05:11:58Z","timestamp":1695618718000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00003072-201901000-00029"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,1]]},"references-count":23,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019]]}},"URL":"https:\/\/doi.org\/10.1097\/rlu.0000000000002329","relation":{},"ISSN":["1536-0229","0363-9762"],"issn-type":[{"value":"1536-0229","type":"electronic"},{"value":"0363-9762","type":"print"}],"subject":[],"published":{"date-parts":[[2019,1]]}}}